Healthcare IT – Medication Adherence Revenue and Competitors

Thonotosassa, FL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Healthcare IT – Medication Adherence's estimated annual revenue is currently $13.9M per year.(i)
  • Healthcare IT – Medication Adherence's estimated revenue per employee is $140,000

Employee Data

  • Healthcare IT – Medication Adherence has 99 Employees.(i)
  • Healthcare IT – Medication Adherence grew their employee count by -3% last year.

Healthcare IT – Medication Adherence's People

NameTitleEmail/Phone
1
VP ManufacturingReveal Email/Phone
2
Director Pharmacy Programs and Network DevelopmentReveal Email/Phone
3
VP, Chief Operating OfficerReveal Email/Phone
4
West Regional ManagerReveal Email/Phone
5
Software ManagerReveal Email/Phone
6
Pharmacy Account ManagerReveal Email/Phone
7
Regional Account ManagerReveal Email/Phone
8
Senior Inside Sales RepresentativeReveal Email/Phone
9
Senior AccountantReveal Email/Phone
10
Software Quality Assurance EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.1M56-8%N/AN/A
#2
$317.9M15888%$332.6MN/A
#3
$150.7M76913%N/AN/A
#4
$32.2M2140%N/AN/A
#5
$4.8M43-14%N/AN/A
#6
$15.5M111-12%$150KN/A
#7
$1.4M17N/AN/AN/A
#8
$1.9M27-7%$54.7MN/A
#9
$1.6M196%N/AN/A
#10
$0.3M4N/AN/AN/A
Add Company

What Is Healthcare IT – Medication Adherence?

Medicine-On-Time is a pioneer in the medication synchronization and multi-dose adherence packaging market. We are experts in compliance as it relates to multi dose medication adherence which provides added confidence for our pharmacy customers. With more than 250 million prescriptions filled across the US, Medicine-On-Time is committed to improving patient quality of life through safe, accurate solutions to medication management.

keywords:N/A

N/A

Total Funding

99

Number of Employees

$13.9M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$51.2M1428%N/A
#2
$136.1M3114%N/A